Bioactives of Momordica charantia as Potential Anti-Diabetic/Hypoglycemic Agents

25Citations
Citations of this article
156Readers
Mendeley users who have this article in their library.

Abstract

Momordica charantia L., a member of the Curcubitaceae family, has traditionally been used as herbal medicine and as a vegetable. Functional ingredients of M. charantia play important roles in body health and human nutrition, which can be used directly or indirectly in treating or preventing hyperglycemia-related chronic diseases in humans. The hypoglycemic effects of M. charantia have been known for years. In this paper, the research progress of M. charantia phytobioactives and their hypoglycemic effects and related mechanisms, especially relating to diabetes mellitus, has been reviewed. Moreover, the clinical application of M. charantia in treating diabetes mellitus is also discussed, hoping to broaden the application of M. charantia as functional food.

Cite

CITATION STYLE

APA

Xu, B., Li, Z., Zeng, T., Zhan, J., Wang, S., Ho, C. T., & Li, S. (2022, April 1). Bioactives of Momordica charantia as Potential Anti-Diabetic/Hypoglycemic Agents. Molecules. MDPI. https://doi.org/10.3390/molecules27072175

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free